Abeona Therapeutics (ABEO) Goodwill & Intangibles (2010 - 2022)
Abeona Therapeutics (ABEO) posted quarterly Goodwill & Intangibles of $2.2 million for Q3 2022, down 93.64% year-over-year from $33.9 million in Q3 2021, and little changed quarter-over-quarter from $2.2 million in Q2 2022.
Analysis
Abeona Therapeutics (ABEO) Goodwill & Intangibles (2010 - 2022) Analysis & Trends
Abeona Therapeutics' Goodwill & Intangibles history runs 12 years deep, the most recent figure standing at $2.2 million for Q3 2022.
- In Q3 2022, Goodwill & Intangibles fell 93.64% year-over-year to $2.2 million; the TTM figure through Sep 2022 stood at $2.2 million (down 93.64% YoY), while the FY2021 annual figure was $1.4 million, down 96.0% from the prior year.
- Goodwill & Intangibles for Q3 2022 stood at $2.2 million, roughly flat from $2.2 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $77.3 million in Q4 2018, with the low at $1.4 million in Q4 2021.
- The 5-year median for Goodwill & Intangibles is $35.1 million (2020), against an average of $38.7 million.
- The sharpest annual moves came in 2018 and 2021: Goodwill & Intangibles jumped 112.18% in 2018, then sank 96.0% in 2021.
- Abeona Therapeutics' Goodwill & Intangibles stood at $77.3 million in 2018, then decreased by 2.91% to $75.1 million in 2019, then plunged by 53.88% to $34.6 million in 2020, then tumbled by 96.0% to $1.4 million in 2021, then surged by 55.78% to $2.2 million in 2022.
- Business Quant data shows ABEO's Goodwill & Intangibles at $2.2 million in Q3 2022, $2.2 million in Q2 2022, and $2.2 million in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 34.62 Mn |
| Jun 30, 2021 | 34.62 Mn |
| Mar 31, 2021 | 34.62 Mn |
| Dec 31, 2020 | 34.66 Mn |
| Sep 30, 2020 | 35.07 Mn |
| Jun 30, 2020 | 35.07 Mn |
| Mar 31, 2020 | 35.07 Mn |
| Dec 31, 2019 | 75.07 Mn |
| Sep 30, 2019 | 75.07 Mn |
| Jun 30, 2019 | 75.07 Mn |
| Mar 31, 2019 | 74.16 Mn |
| Dec 31, 2018 | 77.33 Mn |
| Sep 30, 2018 | 36.18 Mn |
| Jun 30, 2018 | 36.27 Mn |
| Mar 31, 2018 | 36.36 Mn |
| Dec 31, 2017 | 36.44 Mn |